InsidersTradesSigma
레이 Stock: price and insider trades · South Korea · DART (FSS)
Track the 레이 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 레이 has logged 136 public disclosures. Market capitalisation: €70.3bn. The latest transaction was reported on 16 June 2026 (Other). Among the most active insiders: 미래에셋자산운용. Every trade is free.
136
Insider Decl.
0
Thresholds
€3m
27 ops.
Buy Volume
€117,409
68 ops.
Sell Volume
21Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 11,159 of 25,829 companies
55.5
score / 100
Value71
Quality40
FCF yld13%
Earn yld4.5%
EV/EBITDA8.8x
ROE1.3%
Gross mgn47%
Net mgn2.8%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 June 2026
Declarations136 total
25 of 136 declarations
About 레이
레이 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.